Related Experiment Video
Updated: Jun 24, 2026
06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
[Idiosyncratic drug-induced thrombocytopenia]
1Service de médecine interne, diabète et maladies métaboliques, clinique médicale B, hôpitaux universitaires de Strasbourg, 1, porte de l'Hôpital, BP 426, Strasbourg cedex, France.
La Revue De Medecine Interne
|April 11, 2009
Summary
Idiosyncratic drug-induced thrombocytopenia (DIT) is a rare but serious condition. Promptly stopping the offending drug and providing supportive care are key treatments for this platelet disorder.
Area of Science:
- Hematology
- Pharmacology
- Immunology
Context:
- Idiosyncratic drug-induced thrombocytopenia (DIT) is a rare adverse drug reaction.
- Characterized by a significant drop in platelet count (thrombocytopenia) below 100 x 10(9)L.
- Mechanisms include central (production issues) or peripheral (consumption/immune destruction) pathways.
Purpose:
- To review the mechanisms, clinical presentation, diagnosis, and management of DIT.
- To highlight key drug culprits and associated risks, such as thrombosis in heparin-induced thrombocytopenia.
- To discuss the diagnostic utility of clinical criteria and emerging serological tests.
Summary:
- Commonly implicated drugs include heparins, quinidine, sulfonamides, and gold salts.
- Hemorrhagic manifestations are frequent, with severity correlating to platelet count and causative agent.
- Heparin-induced thrombocytopenia (HIT) often presents with thrombotic complications.
- Diagnosis relies on clinical history, criteria for imputability, and potentially serological assays.
- Treatment involves drug withdrawal and supportive care tailored to clinical severity.
Impact:
- Provides a comprehensive overview for clinicians managing DIT.
- Emphasizes the importance of early recognition and appropriate management to prevent severe complications.
- Highlights the diagnostic challenges and the potential role of serological testing in complex cases.
Related Concept Videos
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:01Hypersensitivity Reactions: Cytolytic Reactions
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...